Skip to content

Cervical Cancer Health Center

Medical Reference Related to Cervical Cancer

  1. Endometrial Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] - Significance

    Epidemiology of Endometrial CancerIncidence and mortalityEndometrial cancer is the most common invasive gynecologic cancer in U.S. women, with an estimated 49,560 new cases expected to occur in 2013 and an estimated 8,190 women expected to die of the disease.[1] Endometrial cancer is primarily a disease of postmenopausal women with a mean age at diagnosis of 60 years.[2] Age-adjusted endometrial cancer incidence in the United States has declined since 1975, with a transient increase in incidence occurring from 1973 to 1978, which was associated with estrogen therapy, also known as hormone therapy;[3] there was no associated increase in mortality. From 2005 to 2009, incidence rates of endometrial cancer were stable in white women but increased in African American women by 2.2% per year.[1] The endometrial cancer mortality rates are stable in white women but increased slightly (by 0.4% per year) in African American women from 2005 to 2009.[1] Most cases of endometrial cancer are

  2. Endometrial Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Stage II Endometrial Cancer

    Standard treatment options:If cervical involvement is documented, options include radical hysterectomy, bilateral salpingo-oophorectomy, and pelvic and para-aortic lymph node dissection.If the cervix is clinically uninvolved but extension to the cervix is documented on postoperative pathology, radiation therapy should be considered.The completed GOG-LAP2 trial included 2,616 patients with clinical stage I to IIA disease and randomly assigned them two-to-one to comprehensive surgical staging via laparoscopy or laparotomy.[1] Time to recurrence was the primary endpoint, with noninferiority defined as a difference in recurrence rate of less than 5.3% between the two groups at 3 years. The recurrence rate at 3 years was 10.24% for patients in the laparotomy arm, compared with 11.39% for patients in the laparoscopy arm, with an estimated difference between groups of 1.14% (90% lower bound, -1.278; 95% upper bound, 3.996). Although this difference was lower than the prespecified limit, the

  3. Cervical Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Recurrent Cervical Cancer

    No standard treatment is available for patients with recurrent cervical cancer that has spread beyond the confines of a radiation or surgical field. For locally recurrent disease, pelvic exenteration can lead to a 5-year survival rate of 32% to 62% in selected patients.[1,2] These patients are appropriate candidates for clinical trials testing drug combinations or new anticancer agents. The Gynecologic Oncology Group (GOG) has reported on several randomized phase III trials, (GOG-0179 [NCT00003945], GOG-0240 [NCT00803062]) in this setting. Single-agent cisplatin administered intravenously at 50 mg/m² every 3 weeks was the most-used regimen to treat recurrent cervical cancer since it was initially introduced in the 1970s.[3,4]Various combinations containing cisplatin [3,4] failed to reach their primary endpoint of improving survival, however, a doubling of the cisplatin dose-rate did improve survival. Combinations with paclitaxel and with ifosfamide improved response rates

  4. Cervical Cancer Screening (PDQ®): Screening - Patient Information [NCI] - Risks of Cervical Cancer Screening

    Screening tests have risks.Decisions about screening tests can be difficult. Not all screening tests are helpful and most have risks. Before having any screening test, you may want to discuss the test with your doctor. It is important to know the risks of the test and whether it has been proven to reduce the risk of dying from cancer.The risks of cervical cancer screening include the following: False-negative test results can occur.Screening test results may appear to be normal even though cervical cancer is present. A woman who receives a false-negative test result (one that shows there is no cancer when there really is) may delay seeking medical care even if she has symptoms.False-positive test results can occur.Screening test results may appear to be abnormal even though no cancer is present. Also, some abnormal cells in the cervix never become cancer. A false-positive test result (one that shows there is cancer when there really isn't) can cause anxiety and is usually followed by

  5. Uterine Sarcoma Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Stage Information for Uterine Sarcoma

    Definitions: FIGOThe Féderation Internationale de Gynécologie et d'Obstétrique (FIGO) and the American Joint Committee on Cancer (AJCC) have designated staging to define carcinoma of the corpus uteri, which applies to uterine sarcoma; the FIGO system is most commonly used.[1,2]Uterine sarcomas include leiomyosarcomas, endometrial stromal sarcomas, and adenosarcomas. Table 1. Uterine SarcomaaStagea Adapted from FIGO Committee on Gynecologic Oncology.[1]b Either G1, G2, or G3 (G = grade).c Endocervical glandular involvement only should be considered as stage I and no longer as stage II.d Positive cytology has to be reported separately without changing the stage.IbTumor confined to the corpus uteri.IAbNo or less than half myometrial invasion.IBbInvasion equal to or more than half of the myometrium.IIbTumor invades cervical stroma but does not extend beyond the uterus.cIIIbLocal and/or regional spread of the tumor.IIIAbTumor invades the serosa of the corpus uteri and/or

  6. Endometrial Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - Treatment Option Overview

    There are different types of treatment for patients with endometrial cancer.Different types of treatment are available for patients with endometrial cancer. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.Four types of standard treatment are used: SurgerySurgery (removing the cancer in an operation) is the most common treatment for endometrial cancer. The following surgical procedures may be used: Total hysterectomy: Surgery to remove the uterus, including the cervix. If the uterus and cervix are

  7. Cervical Cancer Prevention (PDQ®): Prevention - Patient Information [NCI] - Changes to This Summary (08 / 22 / 2013)

    The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above. Editorial changes were made to this summary.

  8. Cervical Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Get More Information From NCI

    Call 1-800-4-CANCERFor more information, U.S. residents may call the National Cancer Institute's (NCI's) Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) Monday through Friday from 8:00 a.m. to 8:00 p.m., Eastern Time. A trained Cancer Information Specialist is available to answer your questions.Chat online The NCI's LiveHelp® online chat service provides Internet users with the ability to chat online with an Information Specialist. The service is available from 8:00 a.m. to 11:00 p.m. Eastern time, Monday through Friday. Information Specialists can help Internet users find information on NCI Web sites and answer questions about cancer. Write to usFor more information from the NCI, please write to this address:NCI Public Inquiries Office9609 Medical Center Dr. Room 2E532 MSC 9760Bethesda, MD 20892-9760Search the NCI Web siteThe NCI Web site provides online access to information on cancer, clinical trials, and other Web sites and organizations that offer support

  9. Endometrial Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Changes to This Summary (06 / 14 / 2013)

    The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above. General Information About Endometrial CancerRevised text to state that cancer of the endometrium is the most common gynecologic malignancy in the United States, and irregular vaginal bleeding is an early sign and foremost symptom of the highly curable endometrial tumor.Revised text to state that although the collection of cytology specimen is still suggested, a positive result does not upstage the disease. Stage Information for Endometrial CancerAdded text to state that Féderation Internationale de Gynécologie et d'Obstétrique stages are further subdivided by the histologic grade of the tumor, for example, stage IC G2.Treatment Option OverviewAdded text to state that the results of a study by the Danish Endometrial Cancer Group also suggest that the absence of radiation does not improve the

  10. Cervical Cancer Prevention (PDQ®): Prevention - Patient Information [NCI] - Cervical Cancer Prevention

    Avoiding risk factors and increasing protective factors may help prevent cancer.Avoiding cancer risk factors may help prevent certain cancers. Risk factors include smoking, being overweight, and not getting enough exercise. Increasing protective factors such as quitting smoking, eating a healthy diet, and exercising may also help prevent some cancers. Talk to your doctor or other health care professional about how you might lower your risk of cancer.The following risk factors increase the risk of cervical cancer:HPV InfectionThe most common cause of cervical cancer is infection of the cervix with human papillomavirus (HPV). There are more than 80 types of human papillomavirus. About 30 types can infect the cervix and about half of them have been linked to cervical cancer. HPV infection is common but only a very small number of women infected with HPV develop cervical cancer.HPV infections that cause cervical cancer are spread mainly through sexual contact. Women who become sexually

Displaying 61 - 70 of 161 Articles << Prev Page 3 4 5 6 7 8 9 10 11 12 Next >>

Today on WebMD

cancer cell
HPV is the top cause. Find out more.
doctor and patient
Get to know the Symptoms.
 
sauteed cherry tomatoes
Fight cancer one plate at a time.
Lung cancer xray
See it in pictures, plus read the facts.
 
Integrative Medicine Cancer Quiz
QUIZ
Lifestyle Tips for Depression Slideshow
SLIDESHOW
 
Screening Tests for Women
Slideshow
what is your cancer risk
HEALTH CHECK